Innoviva, Inc. financial data

Symbol
INVA on Nasdaq
Location
1350 Old Bayshore Highway, Suite 400, Burlingame, CA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
THERAVANCE INC (to 12/7/2015), ADVANCED MEDICINE INC (to 8/2/2000)
Latest financial report
10-Q - Q2 2024 - Jul 31, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 996 % +147%
Quick Ratio 117 % +97.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 62.6M shares -3.9%
Common Stock, Shares, Outstanding 62.6M shares -4.08%
Entity Public Float 924M USD +9.88%
Common Stock, Value, Issued 626K USD -4.14%
Weighted Average Number of Shares Outstanding, Basic 62.5M shares -4.31%
Weighted Average Number of Shares Outstanding, Diluted 62.5M shares -4.52%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 330M USD +13.8%
Research and Development Expense 12.8M USD -74.1%
General and Administrative Expense 24.2M USD +28%
Costs and Expenses 177M USD +716%
Operating Income (Loss) 359M USD +4.09%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 153M USD -43.1%
Income Tax Expense (Benefit) 7.57M USD -89.4%
Earnings Per Share, Basic 2.25 USD/shares -33%
Earnings Per Share, Diluted 1.67 USD/shares -34.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 217M USD +25.4%
Inventory, Net 36.7M USD -21.7%
Other Assets, Current 2.15M USD +0.47%
Assets, Current 358M USD +10.7%
Deferred Income Tax Assets, Net 11.4M USD +80.9%
Property, Plant and Equipment, Net 427K USD +165%
Operating Lease, Right-of-Use Asset 3.12M USD +14.7%
Intangible Assets, Net (Excluding Goodwill) 217M USD -10.6%
Goodwill 17.9M USD +20.3%
Other Assets, Noncurrent 2.98M USD -16.3%
Assets 1.22B USD +9.54%
Accounts Payable, Current 2.04M USD -55.6%
Employee-related Liabilities, Current 4.76M USD -13.1%
Liabilities, Current 28.2M USD -28.4%
Deferred Income Tax Liabilities, Net 0 USD
Operating Lease, Liability, Noncurrent 1.98M USD +6.73%
Other Liabilities, Noncurrent 72.1M USD +5.08%
Retained Earnings (Accumulated Deficit) -23.3M USD +86.2%
Stockholders' Equity Attributable to Parent 566M USD +36.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 666M USD +19.9%
Liabilities and Equity 1.22B USD +9.54%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 37M USD +44.2%
Net Cash Provided by (Used in) Financing Activities -9.17M USD +93.3%
Net Cash Provided by (Used in) Investing Activities -43M USD -20.5%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 62.6M shares -4.08%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -15.2M USD +89.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 217M USD +25.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5.18M USD -16.5%
Deferred Tax Assets, Valuation Allowance 169M USD +16.9%
Deferred Tax Assets, Gross 228M USD +12.4%
Operating Lease, Liability 3.43M USD +11.3%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 180M USD -16%
Lessee, Operating Lease, Liability, to be Paid 3.8M USD +12.5%
Operating Lease, Liability, Current 1.45M USD +18.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 435K USD -66.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.71M USD +33.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure -11.9%
Deferred Income Tax Expense (Benefit) 3.24M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 361K USD +24.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 455K USD
Deferred Tax Assets, Operating Loss Carryforwards 182M USD +21.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 230K shares 0%
Unrecognized Tax Benefits 19.4M USD +19.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 325K USD
Operating Lease, Payments 320K USD -17.7%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 25.9M USD +80.6%
Depreciation, Depletion and Amortization 3.5M USD +1.19%
Deferred Tax Assets, Net of Valuation Allowance 58.7M USD +1.11%
Share-based Payment Arrangement, Expense 5.82M USD -28.7%
Interest Expense 22M USD +22.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%